Bioventus (BVS) Finished Goods (2020 - 2026)

Bioventus' Finished Goods history runs 7 years deep, the most recent figure standing at $63.9 million for Q1 2026.

• Quarterly Finished Goods fell 10.28% year-over-year to $63.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.9 million (down 10.28% YoY) and the FY2025 annual result came in at $61.0 million, down 13.33% from the prior year.
• Finished Goods was $63.9 million for Q1 2026 at Bioventus, up from $61.0 million in the prior quarter.
• Across five years, Finished Goods topped out at $75.0 million in Q3 2023 and bottomed at $51.7 million in Q2 2022.
• A 5-year average of $66.5 million and a median of $66.6 million in 2024 frame the typical range for Finished Goods.
• Annual changes were most pronounced in 2022 — Finished Goods soared 75.2% — and 2025, when it dropped 13.33%.
• Bioventus' Finished Goods stood at $66.3 million in 2022, then gained by 5.97% to $70.3 million in 2023, then rose by 0.15% to $70.4 million in 2024, then declined by 13.33% to $61.0 million in 2025, then advanced by 4.74% to $63.9 million in 2026.
• Business Quant data shows BVS's Finished Goods at $63.9 million in Q1 2026, $61.0 million in Q4 2025, and $74.4 million in Q3 2025.